Septerna, Inc. Income Statement
SEPN / Health Care|3 years of annual SEC 10-K data (FY2023-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 3 fiscal years. All figures from audited SEC 10-K filings.
Septerna, Inc. reported $46M in revenue and $49M in net loss for FY2025. Revenue has grown at a 1644.5% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $46.0M | $151.0K | $151.0K |
| SG&A Expense | $29.2M | $9.7M | $9.7M |
| R&D Expense | $97.6M | $36.0M | $36.0M |
| Operating Income | -$68.3M | $2.1M | $2.1M |
| Income Tax | $12.0K | $691.0K | $691.0K |
| Net Income | -$48.9M | $4.2M | $4.2M |
| EPS (Basic) | -$1.10 | $0.29 | $0.29 |
| EPS (Diluted) | -$1.10 | $0.29 | $0.29 |
| Shares Outstanding | 44.8M | 3.2M | 2.2M |
| Operating Margin | -148.6% | 1374.2% | - |
| Profit Margin | -106.4% | 2768.2% | - |